Integer Holdings Corporation
Corporate brand
UnclaimedInteger Holdings Corporation is a medical-device contract manufacturer and technology partner specializing in batteries, power systems, components, and assemblies for implantable and other highly regulated medical devices.
Last updated November 4, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Integer Holdings Corporation is a United States-based medical-device contract development and manufacturing organization. It supplies components, subassemblies, and finished products used by medical-device companies, with a particular emphasis on technologies where reliability, miniaturization, long service life, and regulatory control are critical. Its capabilities span electrochemical power sources, batteries, capacitors, electrodes, lead wires, sensors, delivery systems, and other components used in implantable and minimally invasive devices. The company is best known for supporting medical-technology customers rather than marketing a large portfolio of consumer-facing products under the Integer name. Its customers use Integer technologies in areas including cardiac rhythm management, neuromodulation, structural heart intervention, vascular intervention, pain management, and other specialty-care applications. Integer commonly works across the product life cycle, from design and development through process engineering, manufacturing, testing, sterilization support, and supply-chain services. This business model positions the company as a strategic outsourcing partner for original equipment manufacturers that require specialized production and quality systems. Integer is the successor to the medical-device activities associated with Greatbatch, Inc. Greatbatch had built a major position in implantable power sources and related components, and in 2016 the company changed its corporate name to Integer Holdings Corporation. The rebranding was intended to reflect a broader medical-device technology portfolio and a wider role in outsourced manufacturing. The company retained the New York Stock Exchange ticker ITGR. Its technology base includes primary and rechargeable batteries for implantable devices, as well as capacitors and other power-management components. These products are designed for demanding applications in which battery performance and failure prevention are directly connected to device safety and patient outcomes. Integer also manufactures components and assemblies for lead systems, cardiac devices, neurostimulators, catheters, structural-heart systems, and vascular products. Depending on the program, the company may supply a discrete component, a complex subassembly, or a more complete device manufactured to a customer's specifications. Integer operates internationally, with manufacturing, engineering, and commercial activities serving customers in North America, Europe, and Asia-Pacific. Its competitive proposition is based on technical expertise, quality and regulatory capabilities, manufacturing scale, customer qualification, and the difficulty of transferring validated medical-device production to a new supplier. The company therefore participates in markets that generally have long development cycles, extensive product validation, and significant switching costs. The company does not primarily compete as a standalone consumer medical brand. Instead, its technologies are often incorporated into products sold by larger medical-device manufacturers under their own brands. Integer's current strategy centers on expanding its role in higher-value outsourced medical-device manufacturing, improving operational performance, investing in capacity and technology, and serving growth areas such as cardiac rhythm management, neuromodulation, structural heart, and minimally invasive therapies.
History
Integer Holdings Corporation developed from the medical-device businesses associated with Greatbatch, Inc., a company recognized for its work in implantable power sources and related technologies. Greatbatch's historical capabilities were rooted in the design and manufacture of specialized batteries and other components used in implantable medical devices. These products served applications in which dependable energy delivery, hermeticity, long operating life, and tightly controlled manufacturing were essential. Over time, the business expanded beyond batteries into a wider set of components and assemblies. Its portfolio came to include capacitors, electrodes, lead wires, sensors, catheter-related products, and technologies used in cardiac rhythm management, neuromodulation, vascular intervention, and structural-heart procedures. This expansion reflected the increasing tendency of medical-device original equipment manufacturers to outsource specialized development and production to suppliers with validated processes and regulatory expertise. The company also grew through acquisitions and internal expansion of medical-device manufacturing capabilities. A significant strategic step was the acquisition of medical-device businesses from Lake Region Medical in 2015. That transaction broadened the company's product range and added manufacturing and engineering capabilities in minimally invasive and interventional medical technologies. The combined portfolio helped move the company from a primarily implantable-power specialist toward a more diversified outsourced medical-device partner. In 2016, Greatbatch, Inc. changed its corporate name to Integer Holdings Corporation. The new name was selected to represent the combined business and its broader role in medical-device technologies. The company continued to trade publicly under the ITGR ticker on the New York Stock Exchange. The rebranding did not turn Integer into a consumer-facing device brand; rather, it reinforced its business-to-business identity as a supplier and manufacturing partner whose products are frequently incorporated into devices marketed by other medical companies. During the late 2010s and early 2020s, Integer focused on operational integration, manufacturing quality, capacity, and growth in outsourced medical-device programs. Its activities included design and development support, process development, component manufacturing, assembly, testing, and supply-chain services. The company has targeted areas such as cardiac rhythm management, neuromodulation, structural heart, vascular intervention, and other minimally invasive therapies where specialized manufacturing and regulatory know-how can be important differentiators. Integer changed chief executive leadership in 2022, when Jason Hollar became president and chief executive officer. Under the current model, the company continues to serve medical-device original equipment manufacturers through an international network of engineering and manufacturing operations. Its long-term business characteristics include lengthy customer qualification processes, stringent quality requirements, recurring production programs, and substantial technical barriers to entry. Integer's history is therefore best understood as the evolution of a specialized implantable-power company into a broader contract design and manufacturing organization for advanced medical devices.
- 2022
Jason Hollar becomes chief executive officer
[3]Jason M. Hollar assumed the roles of president and chief executive officer, succeeding the previous leadership team.
- 2016
Corporate rebranding as Integer Holdings Corporation
[2]Greatbatch adopted the Integer Holdings Corporation name to reflect its broader medical-device technology and manufacturing portfolio.
- 2015
Acquisition of Lake Region Medical businesses
[2]Greatbatch acquired Lake Region Medical businesses, expanding its capabilities in outsourced medical-device manufacturing and minimally invasive technologies.
Products and positioning
A specialized, high-reliability medical-device contract manufacturer and component supplier serving original equipment manufacturers. Integer emphasizes engineering depth, regulated manufacturing, design-for-manufacture support, and long-term customer programs rather than consumer brand recognition.
Implantable-device power
Medical batteries and power systems
Integer develops and manufactures primary and rechargeable batteries, battery assemblies, and related power technologies for implantable and other medical devices. These products are engineered for demanding requirements involving energy density, longevity, reliability, packaging, safety, and controlled manufacturing. They support applications such as cardiac rhythm management, neurostimulation, and other devices where dependable power is fundamental to clinical performance.
Medical-device electronics
Capacitors and power-management components
The company supplies capacitors and associated power-management technologies used with implantable medical systems. Such components can support high-power pulse delivery and energy management in devices including implantable cardiac systems. Integer's offering is oriented toward specialized medical applications requiring tightly controlled electrical characteristics, packaging, reliability testing, and regulatory compliance.
Cardiac and neuromodulation components
Electrodes, lead wires, and lead systems
Integer manufactures electrodes, lead wires, and related components used to connect implantable devices with targeted tissue or anatomical sites. These products serve cardiac rhythm-management and neuromodulation applications, where mechanical durability, electrical performance, biocompatibility, and consistent production are critical. The company can support customers with component engineering and manufacturing services tailored to specific device platforms.
Interventional medical devices
Structural-heart and vascular components
Integer provides components, subassemblies, and manufacturing services for structural-heart and vascular devices. The portfolio can include specialized delivery-system and catheter-related technologies used in minimally invasive procedures. These products are generally developed to customer specifications and require controlled materials, precision processing, assembly, inspection, and documentation within regulated medical-device quality systems.
Neuromodulation devices
Neuromodulation and pain-management components
The company supports neuromodulation and pain-management programs with batteries, leads, electrodes, and other components or assemblies. Its role may cover development engineering as well as production, allowing medical-device manufacturers to outsource technically demanding portions of a therapy platform while retaining their own commercial brand and clinical strategy.
Brand decisions
2022
Chief executive leadership transitionOtherBackground
Integer initiated a change in senior leadership as it continued focusing on operational execution and growth in outsourced medical-device manufacturing.
Action taken
Jason M. Hollar became president and chief executive officer.
Aftermath
The leadership transition placed the company under its current chief executive while maintaining its focus on regulated manufacturing, customer programs, and medical-device technology development.
2016
Adoption of the Integer corporate identityStrategyBackground
The legacy Greatbatch identity was increasingly associated with implantable power, while the combined business had developed broader component and manufacturing capabilities.
Action taken
The company changed its corporate name to Integer Holdings Corporation and continued its public-market identity under ticker ITGR.
Aftermath
Integer was positioned as a diversified medical-device technology and contract manufacturing company serving original equipment manufacturers across multiple therapy areas.
2015
Expansion through Lake Region Medical acquisitionM&ABackground
The company sought to broaden its position beyond implantable batteries and become a more comprehensive outsourced medical-device manufacturing partner.
Action taken
Greatbatch acquired Lake Region Medical businesses, adding products, facilities, engineering capabilities, and customer programs in interventional and minimally invasive medical technologies.
Aftermath
The transaction increased the breadth of the company's medical-device portfolio and contributed to the later creation and positioning of the Integer brand.
Recent events
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/integer · Editorial policy · How profiles are compiled